Research

PCORI to Release COVID-19 Targeted Funding

Apr 30, 2020, 13:57 PM by Melodi Moore
pcorilogo






The Patient-Centered Outcomes Research Institute (PCORI) will release its COVID-19 Targeted PCORI Funding Announcement (PFA) on May 5, 2020

This new research funding announcement has an accelerated timeline to support innovative, high-impact studies that fit clearly within our core mission of patient-engaged and patient-centered comparative clinical effectiveness research with up to $30 million funds available. The objectives of this announcement are to strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and provide evidence to inform clinical and public health responses, decision making, and planning. 

This funding announcement’s three targeted priority areas are:

  • Adaptations to healthcare delivery
  • Impact of COVID-19 on vulnerable populations
  • Impact of COVID-19 on healthcare workforce well-being, management, and training

Review the full preannouncement on the PCORI website for more information about this PFA. 

Welcome to the UTMB Research Resources Blog

Sponsored by Research Services, the blog is set up to assist the UTMB research community by disseminating information from various sources in one reliable, relatable and easy to locate place.  Users will be able to find updates from NIH, UT System and UTMB as well as special events and lectures taking place at the University, Galveston and in the area. Available funding opportunities are also included and in most cases broken down by career level for convenience and searching ease.

The blog is designed to be an interactive tool for researchers at all levels.  Readers are encouraged to comment, suggest topics and forward ideas.

Please visit the Research Resources Blog often.  To receive updates of all blog articles, please join the UTMB Research Community Team.  Once there, you can also join the channels you feel would benefit you most.